OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Future of Microbiome‐Based Therapeutics in Clinical Applications
Anukriti Sharma, Promi Das, Mary M. Buschmann, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 1, pp. 123-128
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

New Clinical Applications of Electrolyzed Water: A Review
Pianpian Yan, Eric Banan-Mwine Daliri, Deog‐Hwan Oh
Microorganisms (2021) Vol. 9, Iss. 1, pp. 136-136
Open Access | Times Cited: 90

Scientists’ call to action: Microbes, planetary health, and the Sustainable Development Goals
Thomas W. Crowther, Rino Rappuoli, Cinzia Corinaldesi, et al.
Cell (2024) Vol. 187, Iss. 19, pp. 5195-5216
Open Access | Times Cited: 15

Electrolyzed Water and Its Pharmacological Activities: A Mini-Review
Bo-Kai Chen, Chin‐Kun Wang
Molecules (2022) Vol. 27, Iss. 4, pp. 1222-1222
Open Access | Times Cited: 32

Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice
Tingting Yang, Hao Yang, Heng Cai, et al.
Food & Function (2020) Vol. 11, Iss. 12, pp. 10675-10689
Closed Access | Times Cited: 48

Causal Inference in Microbiome Medicine: Principles and Applications
Bo‐Min Lv, Yuan Quan, Hongyu Zhang
Trends in Microbiology (2021) Vol. 29, Iss. 8, pp. 736-746
Closed Access | Times Cited: 36

Potential Associations Between Microbiome and COVID-19
Huifen Wang, Haiyu Wang, Ying Sun, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34

Modeling Microbial Communities: Perspective and Challenges
Lavanya Raajaraam, Karthik Raman
ACS Synthetic Biology (2024) Vol. 13, Iss. 8, pp. 2260-2270
Open Access | Times Cited: 5

Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells
Jing Wang, Yaqin Hou, Lijun Mu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113570-113570
Closed Access | Times Cited: 5

Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals
Tyson R. Chiaro, Morgan Greenewood, Kaylyn M. Bauer, et al.
Cell Host & Microbe (2025) Vol. 33, Iss. 1, pp. 89-103.e7
Closed Access

From Gut to Glory: Unveiling the Microbiome’s Impact on Human Health
Yogesh Raval, M. Guftar Shaikh, Kiran Dudhat
Regenerative Engineering and Translational Medicine (2025)
Closed Access

The gut microbiome and antipsychotic treatment response
Mary V. Seeman
Behavioural Brain Research (2020) Vol. 396, pp. 112886-112886
Closed Access | Times Cited: 31

Are microbes colimited by multiple resources?
Noelle A. Held, Michael Manhart
Current Opinion in Microbiology (2024) Vol. 80, pp. 102509-102509
Open Access | Times Cited: 3

The Microbiome and the Gut‐Liver‐Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models
Kyle G. Hawkins, Thomas Caleb Casolaro, Jacquelyn A. Brown, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 108, Iss. 5, pp. 929-948
Open Access | Times Cited: 25

Potential role of gut microbiota and its metabolites in radiation-induced intestinal damage
Jiayun Xin, Jie Wang, Qianqian Ding, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 248, pp. 114341-114341
Open Access | Times Cited: 15

Characterization of gut microbiota in patients with stage 3–4 chronic kidney disease: a retrospective cohort study
Xiali Yang, Shi‐Ying Cai, Jinsheng Gong, et al.
International Urology and Nephrology (2023) Vol. 56, Iss. 5, pp. 1751-1762
Closed Access | Times Cited: 9

The rising dominance of microbiology: what to expect in the next 15 years?
Roshan Kumar, Utkarsh Sood, Jasvinder Kaur, et al.
Microbial Biotechnology (2021) Vol. 15, Iss. 1, pp. 110-128
Open Access | Times Cited: 18

Systems to model the personalized aspects of microbiome health and gut dysbiosis
Cristina Matthewman, Alexandra Narin, Hannah Huston, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101115-101115
Open Access | Times Cited: 13

Modelling Human Gut‐Microbiome Interactions in a 3D Bioelectronic Platform
Chrysanthi‐Maria Moysidou, Douglas van Niekerk, Verena Stoeger, et al.
Small Science (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 2

Sex Differences in Gut Microbiota, Hypertension, and Cardiovascular Risk
Anish Sharma, Sahil K. Kapur, Priyal Kancharla, et al.
European Journal of Pharmacology (2024), pp. 177183-177183
Closed Access | Times Cited: 2

Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 15

Investigation of Host–Microbe–Parasite Interactions in an In Vitro 3D Model of the Vertebrate Gut
Chrysanthi‐Maria Moysidou, Aimee Withers, Alasdair J. Nisbet, et al.
Advanced Biology (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 11

Multi-Omics Strategies for Investigating the Microbiome in Toxicology Research
Ethan W. Morgan, Gary H. Perdew, Andrew D. Patterson
Toxicological Sciences (2022) Vol. 187, Iss. 2, pp. 189-213
Open Access | Times Cited: 9

Multicenter analysis of sputum microbiota in tuberculosis patients
Claudia Sala, Andrej Benjak, Delia Goletti, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240250-e0240250
Open Access | Times Cited: 13

Biological therapeutic modalities
Munish Chhabra
Elsevier eBooks (2021), pp. 137-164
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top